Podcast Finding and Treating Inactive Breast Cancer Cells

@vtn read the transcript. Different types of cancer were included, with surprisingly similar results.

"Now, I will tell you that a little over half of the patients in the trial actually had triple-negative breast cancer, about a third of the patients had estrogen receptor-positive breast cancer, and 20% had HER2-positive breast cancer. So, we had all different subtypes of breast cancer. All of the patients had very high-risk features of their disease like, positive lymph nodes, or still had residual cancer after preoperative therapy, things that would put them at high risk of recurrence. But we really saw this effect across all of these different subtypes."

I saw that but when I looked at the clinical trial PALAVY it was only for ER+HER2- participants.

@vtn the transcript says CLEVER study done in Europe. Can you share a link to the PALAVY study?

I have to read transcripts. I cannot absorb podcasts!

I just read about PALAVY on the http://www.govclinicaltrials website. It is recruiting now. But I am HER2+ so I cannot participate.

Just click on it.